Point-of-Care Technology Market Report Evaluates Growth Drivers, Challenges And Market Dynamics

The point-of-care technology sector is poised for significant expansion over the coming years, driven by technological advancements and shifts in healthcare delivery models. As demand for rapid, accessible diagnostic tools grows, this market is set to transform how care is provided both in clinical settings and at home. Let's explore the current market outlook, key players, emerging trends, and segmentation in this fast-evolving industry.

Strong Market Growth Expected for Point-of-Care Technology Through 2030
The point-of-care technology market is forecasted to reach a value of $67.94 billion by 2030, growing at a solid compound annual growth rate (CAGR) of 9.4%. This upward trajectory is largely fueled by innovations in microfluidics and PCR technologies, increasing rates of chronic and lifestyle-related illnesses, expansion of homecare and decentralized healthcare services, growing digitization in healthcare, and supportive regulatory policies promoting rapid diagnostic tests. Key trends likely to influence this market's progress include rising demand for swift diagnostic testing at the care site, broader adoption of home-based and remote testing solutions, growth in portable and handheld diagnostic devices, expanded testing for infectious and chronic diseases, and enhanced focus on ease of use and faster result turnaround.

Download a free sample of the Point-of-Care Technology market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27390&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Driving the Point-of-Care Technology Market
Several prominent organizations are shaping the point-of-care technology landscape today. These include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Cepheid Inc., Radiometer Medical ApS, Nova Biomedical, Sekisui Diagnostics LLC, Abaxis Inc., BHR Biosynex, EKF Diagnostics Holdings plc, Acon Laboratories Inc., Trinity Biotech plc, Chembio Diagnostics Inc., Arkray Inc., and Orchard Software Corporation, along with Point of Care Biomedical Private Limited.

Key Acquisition Highlights Strengthening Market Positions
In July 2024, Switzerland-based pharmaceutical giant F. Hoffmann-La Roche AG acquired a point-of-care technology platform from LumiraDx Group Limited for approximately $350 million. This strategic deal aims to enhance Roche's foothold in decentralized diagnostics by incorporating a user-friendly and portable platform capable of performing immunochemistry and clinical chemistry tests, with potential future applications in molecular diagnostics. LumiraDx Group Limited, headquartered in the UK, specializes in next-generation point-of-care diagnostic technologies.

View the full Point-of-Care Technology market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-technology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Current Trends Transforming the Point-of-Care Technology Industry
Point-of-care technology companies are increasingly focusing on developing advanced, AI-powered diagnostic platforms that improve the accuracy, speed, and accessibility of disease detection. These platforms use artificial intelligence to rapidly analyze medical data, enabling real-time testing for serious conditions like cancer directly at the care site. For example, in February 2025, Canadian diagnostics firm Avitia Inc. launched an AI-integrated platform designed specifically for fast and accurate point-of-care cancer testing. By combining machine learning with portable diagnostic devices, this innovation allows healthcare professionals to provide quick, precise cancer screenings outside of traditional laboratories. This approach shortens turnaround times, enhances early detection, and reduces the need for complex infrastructure, making advanced diagnostics more accessible in remote or underserved communities.

How the Point-of-Care Technology Market Is Structured
The market is segmented across several categories to capture diverse product offerings and application areas:
1) By Product Type: Diagnostics Devices, Monitoring Devices, Therapeutic Devices, and Data Management Systems
2) By Ownership Model: Standalone Solutions, Integrated Solutions, and Cloud-Based Solutions
3) By Technology: Microfluidics, Polymerase Chain Reaction (PCR), and Immunoassays
4) By Application: Infectious Disease Testing, Glucose Monitoring, Cardiometabolic Monitoring, Pregnancy and Fertility Testing, and Other Applications
5) By End-User: Hospitals, Clinics, Homecare Settings, and Ambulatory Surgical Centers

Detailed Subcategories Within the Market
Within diagnostics devices, subsegments include blood glucose monitors, infectious disease testing devices, cardiac marker testing devices, coagulation testing devices, pregnancy and fertility testing devices, urinalysis devices, hematology testing devices, and cholesterol testing devices. Monitoring devices are broken down into vital signs monitors, continuous glucose monitors, cardiac monitors, and respiratory monitors. Therapeutic devices include insulin delivery systems, nebulizers, dialysis machines, and infusion pumps. Data management systems consist of point-of-care data integration systems, middleware solutions, and data analytics platforms. This comprehensive segmentation enables a nuanced understanding of market dynamics and opportunities.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.